Sulphated vinyl polymer in composition for treating retroviral infections
US5292505A · kind A · utility
2Cited by
3References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 15, 1992 |
| Grant date | Mar 8, 1994 |
| Priority date | — |
| Expiry date | Jan 15, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Sulphated vinyl polymers such as sulphated polyvinylalcohol, sulphated copolymers of (meth)acrylic acid and vinylalcohol, and pharmaceutically acceptable salts thereof, have an antiviral effect against human immunodeficiency virus and may therefore be used as a therapeutic agent for treating retrovirus infections like AIDS and AIDS-related diseases. Their antiviral activity is apparently based on inhibition of virus adsorption; their inhibitory effect on giant cell formation is stronger than that of dextran sulphate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.